| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |